Tarkett: information on the total number of voting rights and shares in Tarkett’s share capital as of February 28th, 2021
PARIS, FRANCE, March 8, 2021 - Information on the total number of voting rights and shares in Tarkett’s share capital as of February 28th, 2021
(Article L233-8-II of the French Commercial Code and
Article 223-16 of the General Regulation of the Autorité des marchés financiers)
Date | Total number of shares in the capital | Total number of voting rights |
As of February 28, 2020 | 65,550,281 | Number of theoretical voting rights: 98,345,610 |
Number of exercisable voting rights: 97,936,418 * |
* After deduction of the treasury shares without voting rights.
###
Investor Relations Contact
Tarkett – Emilie Megel – [email protected]
Media contacts
Tarkett - Véronique Bouchard Bienaymé - [email protected]
Brunswick - [email protected] - Tel.: +33 (0) 1 53 96 83 83
About Tarkett
With a history of 140 years, Tarkett is a worldwide leader in innovative flooring and sports surface solutions, with net sales of € 2.6 billion in 2020. Offering a wide range of products including vinyl, linoleum, rubber, carpet, wood, laminate, artificial turf and athletics tracks, the Group serves customers in over 100 countries across the globe. Tarkett has more than 12,000 employees and 33 industrial sites, and sells 1.3 million square meters of flooring every day, for hospitals, schools, housing, hotels, offices, stores and sports fields. Committed to change the game with circular economy and to reducing its carbon footprint, the Group has implemented an eco-innovation strategy based on Cradle to Cradle® principles, fully aligned with its Tarkett Human-Conscious Design™ approach. Tarkett is listed on Euronext Paris (compartment B, ISIN: FR0004188670, ticker: TKTT). www.tarkett.com
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
- YY Group Announces Pricing of Initial Public Offering
- Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!